Biotechnology company Calysta is targeting the growing pet food market in Europe.

Leveraging $39 million in funding, the company’s facility will help meet the need for more sustainable proteins. 

The company is exploring opportunities to expand the presence of its Noochies! brand, as well as explore private label partnerships for its proprietary ingredient range.

The new treat represents the first commercial inclusion of Calysta’s FeedKind® Pet protein.

The company produces sustainable, protein-rich ingredients through biomass fermentation.

This biotechnology expert became an entrepreneur to help accelerate the development of fermented protein ingredients for the pet food industry.

The two companies will begin formulating test diets for regulatory and market evaluation.

The facility will produce PEKILO® mycoprotein ingredients for the aquaculture, pet food and food industries.

The new fermented palatant offers a meaty, umami flavor for cell-cultivated pet foods and treats.

Third-party testing showed the ingredient offers superior digestive and gut health benefits compared to other plant-based sources.